Search

everythinglearnresearchcommunity

for

Search:↓

Improving CRISPR/Cas systems can make gene editing more efficient and precise.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Mechanosensory neurons adapt to different skin types after birth.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

The enzyme RDH12 plays a role in vision and retinal disease, with mutations leading to early onset visual loss and blindness, but the exact disease mechanism is unclear and there are no treatments yet.

IGFBP5 may be a potential target for Parkinson's treatment by reducing neuron death.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

New methods improve stem cell delivery for heart disease, but challenges remain.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

5α-reductase 2 is crucial for stress response in male rats.

3D bioprinted lung cancer models in a mouse-like structure offer a better way to study radiation effects without using live animals.

Caffeine can damage hearing cells and affect hearing recovery after ear trauma.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.

Inducing survivin in normal tissues can protect against radiation damage.

Stem cell-derived exosomes can help repair ear damage and improve balance and hearing.

CaBP1 and CaBP2 are necessary for proper hearing and neurotransmission in the ear's inner hair cells.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Four transcription factors can convert mouse cells into hair cell-like cells, aiding hearing loss research and treatment.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

FGF-7 helps hair grow by activating hair follicles and is a promising target for hair loss treatments.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

LncRNAs play a crucial role in muscle regulation and could help develop treatments for Duchenne muscular dystrophy.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

CRISPR/Cas9 gene-editing shows promise for improving sheep and goat breeding but faces challenges with efficiency and accuracy.